In autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, and psoriasis, aberrant activation of the JAK/STAT pathway, especially involving STAT3 and STAT5, is commonly observed. Here, SOAT1 is linked to autoimmune disease.